Shaun Foy, CFA
Co-Founder & Director

Shaun has served on our Board of Directors since Xap’s founding. He has spent the past 25 years working with emerging healthcare companies as an entrepreneur, investor and advisor.

Shaun co-founded and is an Executive Director of Econic Biosciences, a company focused on developing new cancer therapies that target ecDNA. He also co-founded CRISPR Therapeutics and ERS Genomics, two of the leading companies commercializing the breakthrough CRISPR/Cas9 technology. At CRISPR Therapeutics he served as Chief Business Officer and Chief Financial Officer leading it through its company creation phase and early financings. He is the Chairman of ERS Genomics and was the company’s startup CEO, leading the company through its startup phase and negotiating its initial licensing deals. Shaun previously served as a Partner and one of the founding team members of Nomura Phase4 Ventures, a London-based venture capital group investing in emerging healthcare companies in North America and Europe. Prior to that, he worked with Nomura International’s healthcare corporate finance group advising emerging healthcare companies on M&A and capital raisings.

Shaun received an M.Sc. in Cell Biology & Immunology from the University of British Columbia and is a CFA® charterholder.